Stock priceI don't think Andre cares about the share price at all.. It is very possible that Diagnos makes the long awaited Mexico update, and there are no specific sales figures included in the press release.. That would mean investors would have to wait until those sales flow through the financial statements to know how much value has been earned.. Its not what I want to happen, but certainly is a possibility
Andre is playing Diagnos with a much longer timeline than most tech investors appreciate.. This company was founded 15 years ago, and the share price has done nothing but decline because Andre knows that there are deep pocketed investors like Dundee that will keep the company afloat regardless of what the penny flippers think... That has given Andre the freedom to focus on building the businress for the long-term. But the downside is the share price has no correlation to the success of the underlying business. (Which is also why we are able to buy at such a cheap price).
My prediction is that when the Mexico announcement does come, there will be a muted reaction from the market (share price will go to $0.20).. However, in less than 2 years Diagnos will be bought by Microsoft (or another tech major) for hundreds of millions ($1-$2/share).